Compare ACHV & HOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACHV | HOV |
|---|---|---|
| Founded | N/A | 1959 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 726.5M | 726.0M |
| IPO Year | 2018 | 1994 |
| Metric | ACHV | HOV |
|---|---|---|
| Price | $7.00 | $104.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $14.15 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 83.6K |
| Earning Date | 11-05-2026 | 12-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.55 |
| Revenue | N/A | ★ $2,978,581,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.52 |
| P/E Ratio | ★ N/A | $66.81 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.62 | $91.52 |
| 52 Week High | $8.64 | $148.48 |
| Indicator | ACHV | HOV |
|---|---|---|
| Relative Strength Index (RSI) | 41.70 | 35.36 |
| Support Level | $6.92 | $101.19 |
| Resistance Level | $7.11 | $118.46 |
| Average True Range (ATR) | 0.38 | 3.85 |
| MACD | -0.07 | -0.66 |
| Stochastic Oscillator | 13.10 | 6.80 |
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.
Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations. The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments: Northeast, which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia, and West Virginia; Southeast, which includes Florida, Georgia, and South Carolina; and West, which includes Arizona, California, and Texas. The firm generates maximum revenue from the West Segment.